status of compounded tirzepatide Tirzepatide: A Dual-Action Peptide Compounded Tirzepatide for Weight Loss
Description
In rats, tirzepatide causes thyroid C-cell tumors
15 mg-2 group: 35.7%
Compounded versions may contain different excipients, and their milk transfer properties have not been specifically studied
If any new or concerning symptoms arise, she provides prompt evaluation and tailored guidance
A service of the National Library of Medicine, National Institutes of Health
Marques, A
